Literature DB >> 10619711

Expression, regulation and localisation of dystrophin isoforms in human foetal skeletal and cardiac muscle.

S Torelli1, A Ferlini, L Obici, C Sewry, F Muntoni.   

Abstract

We characterised the expression, localisation and developmental regulation of the three major dystrophin isoforms in human foetal skeletal and cardiac muscles and in the corresponding cultures. Gene expression studies in foetal cardiac muscle-tissue and cultures showed that the Muscle- and the Brain- but not the Purkinje-transcripts were always co-expressed. In skeletal muscle the Muscle-isoform was already present at 11.8 weeks while the Brain-isoform was detected only after 13 weeks. Myoblast cultures showed a similar sequence of isoform transcription. The Purkinje-isoform was never detected. Localisation studies showed that in cardiac muscle dystrophin was seen discontinuously at the sarcolemma from 8.5 weeks, and evenly expressed by 15 weeks. Cardiomyocyte cultures expressed desmin but not dystrophin after 7 days. Protein studies in foetal skeletal muscle suggested that dystrophin is expressed in the cytoplasm from 8.5 weeks and at the sarcolemma only after 10.5 weeks. Similar results were obtained in cultured myoblasts. This study shows that in cardiac muscle both the Muscle- and Brain-isoforms are transcribed in parallel from the very early stages of development, while in skeletal muscle transcription of the Muscle-isoform occurs first, followed by the Brain-isoform.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619711     DOI: 10.1016/s0960-8966(99)00048-6

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  11 in total

Review 1.  What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?

Authors:  Jennifer Manning; Dervla O'Malley
Journal:  J Muscle Res Cell Motil       Date:  2015-02-11       Impact factor: 2.698

2.  Immunohistochemical distribution of desmin in the human fetal heart.

Authors:  Masahito Yamamoto; Shin-ichi Abe; José Francisco Rodríguez-Vázquez; Mineko Fujimiya; Gen Murakami; Yoshinobu Ide
Journal:  J Anat       Date:  2011-04-18       Impact factor: 2.610

3.  In vivo dynamics of skeletal muscle Dystrophin in zebrafish embryos revealed by improved FRAP analysis.

Authors:  Fernanda Bajanca; Vinicio Gonzalez-Perez; Sean J Gillespie; Cyriaque Beley; Luis Garcia; Eric Theveneau; Richard P Sear; Simon M Hughes
Journal:  Elife       Date:  2015-10-13       Impact factor: 8.140

4.  The DMD locus harbours multiple long non-coding RNAs which orchestrate and control transcription of muscle dystrophin mRNA isoforms.

Authors:  Matteo Bovolenta; Daniela Erriquez; Emanuele Valli; Simona Brioschi; Chiara Scotton; Marcella Neri; Maria Sofia Falzarano; Samuele Gherardi; Marina Fabris; Paola Rimessi; Francesca Gualandi; Giovanni Perini; Alessandra Ferlini
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

5.  The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5' X-linked dilated cardiomyopathy.

Authors:  Marcella Neri; Emanuele Valli; Giovanna Alfano; Matteo Bovolenta; Pietro Spitali; Claudio Rapezzi; Francesco Muntoni; Sandro Banfi; Giovanni Perini; Francesca Gualandi; Alessandra Ferlini
Journal:  BMC Med Genet       Date:  2012-03-28       Impact factor: 2.103

Review 6.  Dystrophic Cardiomyopathy: Complex Pathobiological Processes to Generate Clinical Phenotype.

Authors:  Takeshi Tsuda; Kristi K Fitzgerald
Journal:  J Cardiovasc Dev Dis       Date:  2017-09-08

7.  EMQN best practice guidelines for genetic testing in dystrophinopathies.

Authors:  Carl Fratter; Raymond Dalgleish; Stephanie K Allen; Rosário Santos; Stephen Abbs; Sylvie Tuffery-Giraud; Alessandra Ferlini
Journal:  Eur J Hum Genet       Date:  2020-05-18       Impact factor: 4.246

8.  A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential.

Authors:  Gesine Kögler; Sandra Sensken; Judith A Airey; Thorsten Trapp; Markus Müschen; Niklas Feldhahn; Stefanie Liedtke; Rüdiger V Sorg; Johannes Fischer; Claudia Rosenbaum; Susanne Greschat; Andreas Knipper; Jörg Bender; Ozer Degistirici; Jizong Gao; Arnold I Caplan; Evan J Colletti; Graça Almeida-Porada; Hans W Müller; Esmail Zanjani; Peter Wernet
Journal:  J Exp Med       Date:  2004-07-19       Impact factor: 14.307

Review 9.  Non-coding RNAs in muscle dystrophies.

Authors:  Daniela Erriquez; Giovanni Perini; Alessandra Ferlini
Journal:  Int J Mol Sci       Date:  2013-09-30       Impact factor: 5.923

Review 10.  The multifaceted view of heart problem in Duchenne muscular dystrophy.

Authors:  Urszula Florczyk-Soluch; Katarzyna Polak; Józef Dulak
Journal:  Cell Mol Life Sci       Date:  2021-06-06       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.